California Public Employees Retirement System
CRSP icon

California Public Employees Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

California Public Employees Retirement System’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Sell
102,669
-13,438
-12% -$708K ﹤0.01% 1015
2026
Q1 		$5.52M Buy
116,107
+3
+0% +$158 ﹤0.01% 1015
2025
Q4 		$6.09M Buy
116,104
+6,732
+6% +$403K ﹤0.01% 1014
2025
Q3 		$7.09M Buy
109,372
+5,744
+6% +$330K ﹤0.01% 997
2025
Q2 		$5.04M Buy
103,628
+8,011
+8% +$310K ﹤0.01% 1037
2025
Q1 		$3.25M Sell
95,617
-331
-0.3% -$14K ﹤0.01% 1086
2024
Q4 		$3.78M Sell
95,948
-10,908
-10% -$515K ﹤0.01% 1100
2024
Q3 		$5.02M Sell
106,856
-36,284
-25% -$1.84M ﹤0.01% 1087
2024
Q2 		$7.73M Buy
143,140
+35,411
+33% +$2.05M 0.01% 961
2024
Q1 		$7.34M Hold
107,729
– – 0.01% 996
2023
Q4 		$6.74M Sell
107,729
-4,440
-4% -$245K 0.01% 1016
2023
Q3 		$5.09M Buy
112,169
+6,207
+6% +$321K ﹤0.01% 1063
2023
Q2 		$5.95M Hold
105,962
– – 0.01% 1030
2023
Q1 		$4.79M Sell
105,962
-28,915
-21% -$1.4M ﹤0.01% 1086
2022
Q4 		$5.48M Sell
134,877
-12,783
-9% -$678K ﹤0.01% 1088
2022
Q3 		$9.65M Buy
147,660
+17,356
+13% +$1.26M 0.01% 883
2022
Q2 		$7.92M Sell
130,304
-13,329
-9% -$784K 0.01% 922
2022
Q1 		$9.02M Buy
143,633
+9,862
+7% +$619K 0.01% 981
2021
Q4 		$10.1M Sell
133,771
-4,562
-3% -$399K 0.01% 974
2021
Q3 		$15.5M Buy
138,333
+1,072
+0.8% +$135K 0.01% 773
2021
Q2 		$22.2M Sell
137,261
-10,534
-7% -$1.28M 0.02% 645
2021
Q1 		$18M Buy
147,795
+6,226
+4% +$940K 0.01% 738
2020
Q4 		$21.7M Buy
141,569
+19,166
+16% +$2.27M 0.02% 626
2020
Q3 		$10.2M Buy
122,403
+18,600
+18% +$1.65M 0.01% 835
2020
Q2 		$7.63M Buy
103,803
+73,478
+242% +$4.3M 0.01% 960
2020
Q1 		$1.29M Buy
30,325
+1,400
+5% +$72.3K ﹤0.01% 1855
2019
Q4 		$1.76M Buy
28,925
+11,725
+68% +$640K ﹤0.01% 2099
2019
Q3 		$705K Buy
17,200
+3,300
+24% +$158K ﹤0.01% 2440
2019
Q2 		$655K Sell
13,900
-56,600
-80% -$2.26M ﹤0.01% 2403
2019
Q1 		$2.52M Sell
70,500
-2,057
-3% -$71.1K ﹤0.01% 1625
2018
Q4 		$2.07M Buy
72,557
+48,174
+198% +$1.67M ﹤0.01% 1710
2018
Q3 		$1.08M Buy
24,383
+6,589
+37% +$345K ﹤0.01% 2285
2018
Q2 		$1.05M Buy
+17,794
New +$1.01M ﹤0.01% 2304

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

California Public Employees Retirement System's CRSP Position: Q2 2026 in Review

California Public Employees Retirement System reduced its CRISPR Therapeutics (CRSP) stake by 12% in Q2 2026, selling an estimated $708K and leaving 102,669 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

California Public Employees Retirement System first reported a position in CRSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $22.2M in Q2 2021. 522 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • California Public Employees Retirement System held 102,669 shares of CRISPR Therapeutics worth $5.6M as of Q2 2026.
  • California Public Employees Retirement System sold 13,438 CRISPR Therapeutics shares in Q2 2026, an estimated $708K.
  • CRISPR Therapeutics made up ﹤0.01% of California Public Employees Retirement System's portfolio in Q2 2026, its #1015 holding.
  • California Public Employees Retirement System first reported a position in CRISPR Therapeutics in Q2 2018 and has held it in 33 quarters since.
  • California Public Employees Retirement System's CRISPR Therapeutics position peaked at $22.2M in Q2 2021.
  • 522 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on California Public Employees Retirement System's 13F filing for Q2 2026, filed 14 Aug 2026.